$SIGA
SIGA Technologies Inc

2020 Q1 Form 10-Q Financial Statement

#000143774920009619 Filed on May 06, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $2.620M $10.46M
YoY Change -74.95% 498.34%
Cost Of Revenue $109.1K $915.0K
YoY Change -88.08%
Gross Profit $2.511M $9.544M
YoY Change -73.69% 446.0%
Gross Profit Margin 95.84% 91.25%
Selling, General & Admin $3.176M $3.167M
YoY Change 0.3% 3.58%
% of Gross Profit 126.5% 33.18%
Research & Development $3.150M $3.997M
YoY Change -21.19% 32.89%
% of Gross Profit 125.47% 41.88%
Depreciation & Amortization $133.2K $137.7K
YoY Change -3.31% 362.32%
% of Gross Profit 5.3% 1.44%
Operating Expenses $6.326M $8.267M
YoY Change -23.48% 31.58%
Operating Profit -$3.998M $2.192M
YoY Change -282.4% -148.33%
Interest Expense $3.017M $3.928M
YoY Change -23.21% 4.79%
% of Operating Profit 179.22%
Other Income/Expense, Net $412.4K $736.1K
YoY Change -43.98% 32836.42%
Pretax Income -$11.60M $2.136M
YoY Change -643.09% -118.44%
Income Tax -$2.700M $506.2K
% Of Pretax Income 23.7%
Net Earnings -$8.898M $1.630M
YoY Change -645.94% -114.07%
Net Earnings / Revenue -339.63% 15.58%
Basic Earnings Per Share -$0.11 $0.02
Diluted Earnings Per Share -$0.11 -$0.02
COMMON SHARES
Basic Shares Outstanding 81.24M 80.91M
Diluted Shares Outstanding 81.24M 82.14M

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $77.40M $102.1M
YoY Change -24.19% 634.53%
Cash & Equivalents $77.38M $102.1M
Short-Term Investments
Other Short-Term Assets $2.600M $15.40M
YoY Change -83.12% 20.31%
Inventory $16.34M $2.017M
Prepaid Expenses
Receivables $1.686M $4.100M
Other Receivables $0.00 $0.00
Total Short-Term Assets $98.02M $123.5M
YoY Change -20.65% 299.38%
LONG-TERM ASSETS
Property, Plant & Equipment $2.501M $2.987M
YoY Change -16.29% 2644.54%
Goodwill $898.3K $898.3K
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $848.0K $993.0K
YoY Change -14.6% 41.41%
Total Long-Term Assets $20.55M $82.90M
YoY Change -75.21% -18.89%
TOTAL ASSETS
Total Short-Term Assets $98.02M $123.5M
Total Long-Term Assets $20.55M $82.90M
Total Assets $118.6M $206.4M
YoY Change -42.56% 55.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.766M $2.150M
YoY Change 121.71% 397.36%
Accrued Expenses $16.66M $9.958M
YoY Change 67.29% 177.67%
Deferred Revenue $13.60M
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $21.42M $12.11M
YoY Change 76.95% 201.3%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $76.70M
YoY Change -100.0% 6.23%
Other Long-Term Liabilities $9.000M $11.60M
YoY Change -22.41% -97.04%
Total Long-Term Liabilities $9.000M $88.30M
YoY Change -89.81% -80.96%
TOTAL LIABILITIES
Total Short-Term Liabilities $21.42M $12.11M
Total Long-Term Liabilities $9.000M $88.30M
Total Liabilities $30.43M $100.4M
YoY Change -69.68% -78.54%
SHAREHOLDERS EQUITY
Retained Earnings -$132.9M -$114.2M
YoY Change 16.43% -57180.74%
Common Stock $221.1M $220.2M
YoY Change 0.38% 2.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $88.14M $106.1M
YoY Change
Total Liabilities & Shareholders Equity $118.6M $206.4M
YoY Change -42.56% 55.06%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income -$8.898M $1.630M
YoY Change -645.94% -114.07%
Depreciation, Depletion And Amortization $133.2K $137.7K
YoY Change -3.31% 362.32%
Cash From Operating Activities $3.322M $9.379K
YoY Change 35324.32% -100.11%
INVESTING ACTIVITIES
Capital Expenditures -$20.00K -$10.00K
YoY Change 100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$15.50K -$8.951K
YoY Change 73.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $993.4K $0.00
YoY Change
Debt Paid & Issued, Net $85.91M
YoY Change
Cash From Financing Activities -$86.92M -56.59K
YoY Change 153490.0%
NET CHANGE
Cash From Operating Activities $3.322M 9.379K
Cash From Investing Activities -$15.50K -8.951K
Cash From Financing Activities -$86.92M -56.59K
Net Change In Cash -$83.61M -56.16K
YoY Change 148772.25% -99.34%
FREE CASH FLOW
Cash From Operating Activities $3.322M $9.379K
Capital Expenditures -$20.00K -$10.00K
Free Cash Flow $3.342M $19.38K
YoY Change 17147.78%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
Siga Technologies INC
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001010086
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
81047424
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q1 dei Security12b Title
Security12bTitle
Common stock, par value $.0001, per share
CY2020Q1 dei Trading Symbol
TradingSymbol
siga
CY2020Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
955494
CY2019Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2966139
CY2020Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16658698
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8636911
CY2020Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
401073
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
288707
CY2020Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
340242
CY2019Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
256402
CY2020Q1 siga Accrued Research And Development Vendor Costs Current
AccruedResearchAndDevelopmentVendorCostsCurrent
231832
CY2019Q4 siga Accrued Research And Development Vendor Costs Current
AccruedResearchAndDevelopmentVendorCostsCurrent
707685
CY2020Q1 siga Conversion Of Warrants To Common Stock
ConversionOfWarrantsToCommonStock
CY2019Q1 siga Conversion Of Warrants To Common Stock
ConversionOfWarrantsToCommonStock
1172801
CY2020Q1 siga Gain Loss On Change In Fair Value Of Warrant Liability
GainLossOnChangeInFairValueOfWarrantLiability
16065
CY2019Q1 siga Gain Loss On Change In Fair Value Of Warrant Liability
GainLossOnChangeInFairValueOfWarrantLiability
-3136265
CY2020Q1 siga Increase Decrease In Deferred Tax Assets
IncreaseDecreaseInDeferredTaxAssets
-700000
CY2019 siga Lessee Operating Lease First Renewal Term
LesseeOperatingLeaseFirstRenewalTerm
P2Y
CY2019 siga Lessee Operating Lease Second Renewal Term
LesseeOperatingLeaseSecondRenewalTerm
P3Y
CY2020Q1 siga Patent Preparation Fees
PatentPreparationFees
182597
CY2019Q1 siga Patent Preparation Fees
PatentPreparationFees
187916
CY2019Q1 siga Stock Issued During Period Value Stock Settled Appreciation Rights Exercised
StockIssuedDuringPeriodValueStockSettledAppreciationRightsExercised
CY2019Q1 siga Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
1172801
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
4765817
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3054032
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1685642
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4167996
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3859476
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3726313
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
221057307
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
220808037
CY2020Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
9746
CY2019Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
56590
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
259016
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
408894
CY2020Q1 us-gaap Assets
Assets
118574463
CY2019Q4 us-gaap Assets
Assets
198566190
CY2020Q1 us-gaap Assets Current
AssetsCurrent
98022808
CY2019Q4 us-gaap Assets Current
AssetsCurrent
180041785
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
77377300
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
65249072
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
102085215
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
100652809
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
160986934
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
180396910
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
77377300
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
180340748
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-83609634
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-56162
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
81047424
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
81269868
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
81047424
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
81269868
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
8105
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
8127
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
13601728
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2298341
CY2020Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
100000
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
109094
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
915367
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
6617820
CY2019Q1 us-gaap Costs And Expenses
CostsAndExpenses
8267130
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2153695
CY2019Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
505678
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
133163
CY2019Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
137724
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.233
CY2019Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.237
CY2020Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
CY2019Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3136265
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
16065
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
6116882
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
6132947
CY2020Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-4981461
CY2019Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
CY2020Q1 us-gaap Goodwill
Goodwill
898334
CY2019Q4 us-gaap Goodwill
Goodwill
898334
CY2020Q1 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-11600000
CY2019Q1 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
2100000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-11600035
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2135930
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2702506
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
506153
CY2020Q1 us-gaap Income Tax Receivable
IncomeTaxReceivable
700000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1624681
CY2019Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1181885
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2482354
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2140821
CY2020Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
11303389
CY2019Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1277828
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4086487
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-891133
CY2020Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-22259
CY2019Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-508400
CY2020Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
CY2019Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
1225788
CY2020Q1 us-gaap Interest Expense
InterestExpense
3016817
CY2019Q1 us-gaap Interest Expense
InterestExpense
3928418
CY2020Q1 us-gaap Interest Payable Current
InterestPayableCurrent
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
977724
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3998055
CY2020Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
959398
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
959398
CY2020Q1 us-gaap Inventory Net
InventoryNet
16342014
CY2019Q4 us-gaap Inventory Net
InventoryNet
9652855
CY2020Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2602672
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
CY2020Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
12779944
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
8693457
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3154079
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
982880
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
404258
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
402078
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
368467
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
600362
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
396034
CY2020Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
449481
CY2020Q1 us-gaap Liabilities
Liabilities
30432341
CY2019Q4 us-gaap Liabilities
Liabilities
100782434
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
118574463
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
198566190
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
21424515
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
91735809
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-86916580
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-56590
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15501
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8951
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3322447
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9379
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-8897529
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
1629777
CY2020Q1 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-8897529
CY2019Q1 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-1506488
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
412363
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
736129
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2944932
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0453
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y36D
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2191954
CY2020Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
100000
CY2019Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
100000
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
2704598
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
427064
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
419709
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
100000
CY2019Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
100000
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2944932
CY2020Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
701265
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
722204
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
847983
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
856766
CY2020Q1 us-gaap Other Liabilities
OtherLiabilities
2874879
CY2019Q4 us-gaap Other Liabilities
OtherLiabilities
2929743
CY2020Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
887132
CY2019Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
1108916
CY2020Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
15501
CY2019Q1 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
8951
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
993375
CY2019Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9746
CY2019Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
56590
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2617852
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5234000
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6360117
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6344616
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2500641
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2618303
CY2019Q4 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
22500000
CY2020Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
85913459
CY2019Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3150105
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3997281
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
95737862
CY2020Q1 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
16304697
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
14151002
CY2020Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
CY2019Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
95737862
CY2019Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
11461290
CY2018Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
11452078
CY2019Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
66794243
CY2018Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
68292023
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-132923290
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-123032408
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2619765
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10459084
CY2020Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
47000000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3176024
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3166566
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
259016
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
408894
CY2020Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
CY2019Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
80044866
CY2020Q1 us-gaap Stock Issued1
StockIssued1
CY2019Q1 us-gaap Stock Issued1
StockIssued1
118500
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
CY2020Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
50000000
CY2020Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
225094
CY2020Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
993375
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
88142122
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
97783756
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
102914687
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
106069569
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80913320
CY2020Q1 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
19000
CY2020Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
6132947
CY2019Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
6116882
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81240105
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
82139108
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81240105

Files In Submission

Name View Source Status
0001437749-20-009619-index-headers.html Edgar Link pending
0001437749-20-009619-index.html Edgar Link pending
0001437749-20-009619.txt Edgar Link pending
0001437749-20-009619-xbrl.zip Edgar Link pending
ex_176278.htm Edgar Link pending
ex_176279.htm Edgar Link pending
ex_176280.htm Edgar Link pending
ex_176282.htm Edgar Link pending
ex_184040.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
siga-20200331.xml Edgar Link completed
siga-20200331.xsd Edgar Link pending
siga-20200331_cal.xml Edgar Link unprocessable
siga-20200331_def.xml Edgar Link unprocessable
siga-20200331_lab.xml Edgar Link unprocessable
siga-20200331_pre.xml Edgar Link unprocessable
siga20200331_10q.htm Edgar Link pending